Takao, Tomoka
Sato, Masato
Fujisawa, Yuki
Toyoda, Eriko
Yamada, Daisuke
Hitsumoto, Yukio
Nakata, Eiji
Ozaki, Toshifumi
Takarada, Takeshi http://orcid.org/0000-0002-2363-7704
Funding for this research was provided by:
Japan Society for the Promotion of Science (21H02643)
Japan Agency for Medical Research and Development (18bm0704024h0001)
Article History
Received: 12 September 2022
Accepted: 9 February 2023
First Online: 24 February 2023
Declarations
:
: The Ethics Committee of Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, approved the experimental protocols for studies of human subjects about using human pluripotent stem cells (project title; Molecular analysis of the process of human skeletal development using human iPS cells, approval number; K1707-013, date of approval; December 6, 2019).
: Not applicable.
: All data generated or analyzed during this study are included in this article.
: T. Takao, DY, and T. Takarada have a patent pending related to this work (PCT/JP2020/03551). MS perceives funding from CellSeed Inc. MS is one of the inventors on the patents (PCT/JP2006/303759, PCT/JP2017/031136) held by the applicants Tokai University and CellSeed Inc. for the manufacturing process of chondrocyte sheets. Other authors declare no competing interests.